Conversely, CD4+ T cells from CAPS patients, which express constitutively-active NLRP3, produce uncontrolled IL-1β and have pathologically increased Th1 activity that can be normalized by the specific NLRP3 inhibitor MCC95011,15. The gene discussed is CD4; the disease is cryopyrin-associated periodic syndrome.